Profitability Ratios
| Ratio |
Value |
| GP Margin |
93.7% |
| EBIT Margin |
41.4% |
| EBITDA Margin |
43.8% |
| Operating Margin |
50.1% |
| Pretax Margin |
39.4% |
| Cont. Ops Margin |
39.2% |
| Net Margin |
39.2% |
| Bottom Line Margin |
39.2% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
2.13 |
| Quick Ratio |
2.10 |
| Solvency Ratio |
0.359 |
| Cash Ratio |
0.52 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.01 |
| Forward PEG |
-0.01 |
| Price/Book |
-8.52 |
| Price/Sales |
0.97 |
| Price/FCF |
-4.35 |
| Price/Op Cash Flow |
-4.45 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.2115 |
| Debt/Equity |
-1.9476 |
| Debt/Capital |
2.0553 |
| Long-Term Debt/Capital |
2.0776 |
| Financial Leverage |
-9.21 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
4.56 |
| Operating Cash Flow Ratio |
-0.532 |
| Operating Cash Flow/Sales |
-21.8% |
| Free Cash Flow/Operating Cash Flow |
102.3% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
19.58 |
| Interest Coverage |
24.9821 |
| Short-Term Operating Cash Flow Coverage |
-97.58 |
| Operating Cash Flow Coverage |
-0.98 |
| Capital Expenditure Coverage |
-44.00 |
| Dividend + Capital Expenditure Coverage |
-44.00 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
6.94 |
| EPS |
2.718 |
| Debt/Share |
1.6751 |
| Cash/Share |
4.54 |
| Book Value/Share |
-0.79 |
| Tangible BV/Share |
-1.49 |
| Equity/Share |
-0.79 |
| Operating Cash Flow/Share |
-1.510 |
| Capital Expenditure/Share |
0.034 |
| FCF/Share |
-1.544 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.996 |
| Earnings Before Tax/EBIT |
0.785 |
| Price/Fair Value |
-8.52 |
| Debt/Market Cap |
0.2286 |
| Effective Tax Rate |
0.4% |
| Enterprise Value Multiple |
2.23 |
NVAX - Novavax, Inc.